Burning Rock Biotech Limited
BNR
$2.90
-$0.04-1.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 49.70% | 79.33% | 37.47% | 37.47% | 26.17% |
| Total Depreciation and Amortization | -60.76% | -- | -- | -- | 7.14% |
| Total Amortization of Deferred Charges | -58.12% | -- | -- | -- | -42.75% |
| Total Other Non-Cash Items | 30.87% | -95.66% | 7.50% | 7.50% | 79.65% |
| Change in Net Operating Assets | 29.70% | -- | -- | -- | -359.99% |
| Cash from Operations | 219.44% | 35.39% | 66.13% | 66.13% | 76.72% |
| Capital Expenditure | 32.88% | -- | -- | -- | 88.65% |
| Sale of Property, Plant, and Equipment | 1,775.86% | -- | -- | -- | -96.59% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.30% | 49.69% | 43.99% | 43.99% | -87.95% |
| Cash from Investing | -148.68% | 49.69% | 43.99% | 43.99% | 93.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 98.97% | -- | -- | -- | 90.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.04% | 100.00% | -- | -- | -92.10% |
| Cash from Financing | 96.10% | 100.00% | -- | -- | 81.35% |
| Foreign Exchange rate Adjustments | 275.77% | -188.78% | 101.03% | 101.03% | 45.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 211.48% | 63.53% | 66.80% | 66.80% | 76.12% |